United Kingdom · Question · Written question
UIN 195639
Vaccination: Manufacturing Industries
Original
Introduced
1 September 2023
Last action
8 September 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
8 September 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to his Department’s paper A review of the Vaccine Taskforce, published on 29 August 2023, what funds the Office for Life Sciences has to invest in additional vaccine production capac
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 September 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to his Department’s paper A review of the Vaccine Taskforce, published on 29 August 2023, what funds the Office for Life Sciences has to invest in additional vaccine production capac
Source: Commons
8 September 2023
Answer
Through the Vaccine Taskforce, over £405 million was invested in the United Kingdom’s vaccine manufacturing capabilities across several modalities, to ensure a robust response to COVID-19 and future health emergencies. In December 2022 the Government sign...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-09-01/195639
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1655804
- uk · wq-1655804 · source updated 8 September 2023